BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17988798)

  • 1. Mucin-type O-glycosylation and its potential use in drug and vaccine development.
    Tarp MA; Clausen H
    Biochim Biophys Acta; 2008 Mar; 1780(3):546-63. PubMed ID: 17988798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
    Bennett EP; Mandel U; Clausen H; Gerken TA; Fritz TA; Tabak LA
    Glycobiology; 2012 Jun; 22(6):736-56. PubMed ID: 22183981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
    J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
    Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
    Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
    Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
    Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
    Hassan H; Reis CA; Bennett EP; Mirgorodskaya E; Roepstorff P; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
    J Biol Chem; 2000 Dec; 275(49):38197-205. PubMed ID: 10984485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
    Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
    Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.
    Hanisch FG; Reis CA; Clausen H; Paulsen H
    Glycobiology; 2001 Sep; 11(9):731-40. PubMed ID: 11555617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
    Pedersen JW; Bennett EP; Schjoldager KT; Meldal M; Holmér AP; Blixt O; Cló E; Levery SB; Clausen H; Wandall HH
    J Biol Chem; 2011 Sep; 286(37):32684-96. PubMed ID: 21768105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides.
    Tetaert D; Ten Hagen KG; Richet C; Boersma A; Gagnon J; Degand P
    Biochem J; 2001 Jul; 357(Pt 1):313-20. PubMed ID: 11415465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
    Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
    Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
    Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
    BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.